Phathom Pharmaceuticals I... (PHAT)
6.79
0.00 (0.00%)
At close: Jan 15, 2025, 11:41 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| PE Ratio | -2.32 | -1.97 | -4.91 | -8.28 | -3.67 | -163.84 |
| PS Ratio | 686.61 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | -6.44 | -5.87 | 10.09 | 5.68 | 3.38 | -164.09 |
| P/FCF Ratio | -3.36 | -2.97 | -4.89 | -15.61 | -12.47 | -206.28 |
| P/OCF Ratio | -3.4 | -3 | -4.9 | -15.84 | -21.09 | -206.28 |
| OCF/S Ratio | -201.73 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -1.91 | -1.3 | 1.27 | 0.25 | 0.10 | -1.52 |
| Quick Ratio | 10.22 | 6.12 | 9.86 | 5.25 | 68.20 | 0.41 |
| Current Ratio | 10.25 | 6.12 | 9.86 | 5.25 | 68.20 | 0.41 |
| Asset Turnover | 0.00 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -3.99 | -6.32 | -19.9 | -27.43 | -25.43 | -94.23 |
| Return on Equity (ROE) | 2.77 | 2.98 | -2.05 | -0.69 | -0.92 | 1.00 |
| Return on Assets (ROA) | -0.49 | -1.35 | -0.78 | -0.45 | -0.82 | -1.43 |
| Return on Capital (ROIC) | -0.45 | -1.24 | -0.79 | -0.52 | -0.42 | 0.95 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 75.51% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -29.56K% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -29.56K% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -24.53K% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -20.41K% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -23.32K% | n/a | n/a | n/a | n/a | n/a |